当前位置:首页 - 行情中心 - 鲁抗医药(600789) - 财务分析

鲁抗医药

(600789)

  

流通市值:90.05亿  总市值:90.05亿
流通股本:8.99亿   总股本:8.99亿

鲁抗医药(600789)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.47亿元,每股收益0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益410482.94万元,未分配利润117559.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产881636.72万元,负债471153.78万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入4,624,350,443.623,153,993,569.881,673,699,598.016,233,090,168.38
营业总成本4,428,403,914.862,972,941,889.511,603,575,969.645,966,978,980.46
其他经营收益
营业利润190,331,396.54146,923,738.3285,861,702.38436,189,761.86
利润总额186,336,080.99142,932,282.7286,029,587.01433,901,412.51
净利润146,619,239.95110,648,217.6582,348,970.57408,347,521.83
每股收益
其他综合收益-1,986,272.05-1,387,189.78-1,306,169.17-7,452,241.92
综合收益总额144,632,967.9109,261,027.8781,042,801.4400,895,279.91
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计3,814,446,929.583,916,634,147.394,169,336,837.374,130,301,803.62
非流动资产:
非流动资产合计5,001,920,232.854,970,728,841.834,966,570,142.344,967,683,072.8
资产总计8,816,367,162.438,887,362,989.229,135,906,979.719,097,984,876.42
流动负债:
流动负债合计3,190,669,440.873,145,711,765.353,259,579,625.773,060,932,068.62
非流动负债:
非流动负债合计1,520,868,329.461,650,302,009.361,733,613,899.561,975,482,433.06
负债合计4,711,537,770.334,796,013,774.714,993,193,525.335,036,414,501.68
所有者权益(或股东权益):
归属于母公司股东权益合计3,957,023,996.463,944,150,813.153,995,576,973.313,918,185,214.35
股东权益合计4,104,829,392.14,091,349,214.514,142,713,454.384,061,570,374.74
负债和股东权益合计8,816,367,162.438,887,362,989.229,135,906,979.719,097,984,876.42
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,901,835,418.372,631,087,931.491,280,615,436.195,519,103,108.2
经营活动现金流出小计3,595,892,858.792,318,750,652.911,253,744,242.535,116,285,051.07
经营活动产生的现金流量净额305,942,559.58312,337,278.5826,871,193.66402,818,057.13
投资活动产生的现金流量:
投资活动现金流入小计94,701,901.729,084,163.258,017.420,312,302.24
投资活动现金流出小计209,213,507.48134,413,489.7968,060,294.89279,181,894.96
投资活动产生的现金流量净额-114,511,605.78-105,329,326.59-68,002,277.49-258,869,592.72
筹资活动产生的现金流量:
筹资活动现金流入小计1,349,991,458.24861,378,558.24601,000,0001,858,560,025.4
筹资活动现金流出小计1,495,642,130.78984,161,885.46605,003,435.492,047,659,990.38
筹资活动产生的现金流量净额-145,650,672.54-122,783,327.22-4,003,435.49-189,099,964.98
汇率变动对现金及现金等价物的影响4,725,522.795,177,073.161,019,984.4910,806,795.17
现金及现金等价物净增加额50,505,804.0589,401,697.93-44,114,534.83-34,344,705.4
期末现金及现金等价物余额546,206,996.02585,102,889.9452,094,745.14495,701,191.97
补充资料:
现金及现金等价物的净增加额-89,401,697.93--34,344,705.4
TOP↑